Stefanie S. Jeffrey, MD
Publication Details
-
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.
Breast Cancer Res. 2007; (3): R30
Gene expression profiling of breast carcinomas has increased our understanding of the heterogeneous biology of this disease and promises to impact clinical care. The aim of this study was to evaluate the prognostic value of gene expression-based classification along with established prognostic markers and mutation status of the TP53 gene (tumour protein p53) in a group of breast cancer patients with long-term (12 to 16 years) follow-up.
Help
Trial Administration